Results of the analysis presented here identified basic leucine zipper and W2 domains 1 (BZW1), misshapen-like kinase 1 (MINK1), pleckstrin homology domain containing M3 (PLEKHM3), and replication factor C subunit 2 (RFC2) as potential diagnostic biomarkers in GBM. This evidence concerns the gene BZW1 and glioblastoma.